A detailed history of Timber Creek Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Timber Creek Capital Management LLC holds 1,575 shares of BMY stock, worth $86,168. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,575
Previous 1,575 -0.0%
Holding current value
$86,168
Previous $85,000 23.53%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022

SELL
$53.63 - $62.52 $421,531 - $491,407
-7,860 Reduced 83.31%
1,575 $98,000
Q3 2021

Oct 08, 2021

SELL
$59.17 - $69.31 $5,029 - $5,891
-85 Reduced 0.89%
9,435 $558,000
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $326,575 - $355,640
-5,275 Reduced 35.65%
9,520 $636,000
Q1 2021

Apr 19, 2021

SELL
$59.34 - $66.74 $1.8 Million - $2.03 Million
-30,360 Reduced 67.24%
14,795 $934,000
Q4 2020

Jan 25, 2021

BUY
$57.74 - $65.43 $41,861 - $47,436
725 Added 1.63%
45,155 $2.8 Million
Q3 2020

Oct 20, 2020

SELL
$57.43 - $63.64 $935,534 - $1.04 Million
-16,290 Reduced 26.83%
44,430 $2.68 Million
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $21,105 - $24,674
385 Added 0.64%
60,720 $3.57 Million
Q1 2020

Apr 17, 2020

BUY
$46.4 - $67.43 $267,728 - $389,071
5,770 Added 10.57%
60,335 $3.36 Million
Q4 2019

Jan 30, 2020

BUY
$49.21 - $64.19 $77,997 - $101,741
1,585 Added 2.99%
54,565 $3.5 Million
Q3 2019

Oct 31, 2019

BUY
$42.77 - $50.71 $175,570 - $208,164
4,105 Added 8.4%
52,980 $2.69 Million
Q2 2019

Aug 05, 2019

BUY
$44.62 - $49.34 $786,650 - $869,864
17,630 Added 56.43%
48,875 $2.22 Million
Q1 2019

Apr 23, 2019

BUY
$45.12 - $53.8 $64,521 - $76,934
1,430 Added 4.8%
31,245 $1.49 Million
Q4 2018

Jan 30, 2019

BUY
$48.76 - $63.23 $1.37 Million - $1.78 Million
28,190 Added 1734.77%
29,815 $1.55 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,625
1,625 $88,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $116B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Timber Creek Capital Management LLC Portfolio

Follow Timber Creek Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Timber Creek Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Timber Creek Capital Management LLC with notifications on news.